The identification of targetable chimeric fusions in single cases of for example FN1–IGF1R positive IMT and NBPF1–IGF1R positive GIST (Table 1) emphasize the need for personalized genetic profiling to determine the optimal treatment regimens for these patients. Here, IGF1R is linked to gastrointestinal stromal tumor.